> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Biosimilar User Fee Rates for FY 2021
- URL: https://www.fdaweb.com/biosimilar-user-fee-rates-for-fy-2021/
- Published: 2020-08-04T12:00:00.000Z
- Updated: 2026-09-14T16:23:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147342

*Federal Register* notice: FDA has announced the rates for biosimilar user fees for fiscal year 2021\. For example, the fee for a biosimilar application requiring clinical data is $1.7 million, and the initial biological product development fee is $102,000\. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-08-04/pdf/2020-16858.pdf?ref=fdaweb.com).